Metabolism Disorder TRIZ Cases

Lactobacillus rhamnosus CGMCC 1.3724 reduces body weight while avoiding sensitivity reactions caused by t10c12-octadecadienoic acid overproduction.

Antibodies inhibit PCSK9 to boost LDL receptor expression, addressing insufficient statin efficacy in high-risk patients.

A synbiotic composition uses probiotic strains to produce specific prebiotic oligosaccharides via reverse enzyme reactions.

Composite formulation combining docosahexaenoic acid, coenzyme Q10, lipoic acid, and phospholipid reduces cholesterol while addressing high mortality rates.

Poncirin and eriodictyol compounds reduce liver fat content without worsening liver function or causing adverse effects.

Merging GLP-1 and cyclic PYY sequences extends circulating half-life, overcoming rapid metabolism to sustain therapeutic potential.

GDF15 polypeptide administration reduces blood glucose and insulin levels, addressing inadequate management of Type 2 diabetes and obesity.

Albumin-bound insulin compound extends glucose control duration to 72 hours, reducing nocturnal hypoglycemia risk through a flat pharmacokinetic profile.

Chromatography on a multimodal ligand resin maintains the intact 130 kDa glycoprotein structure while achieving high purity and yield.

An IL-22 dimer extends serum half-life to treat pancreatitis by reducing amylase levels, inhibiting necrosis, and ameliorating pancreatic edema.

Histidine buffers semaglutide solutions to prevent impurity formation during storage and light exposure.

Administering a phosphorus-binding composition with aluminum stabilizes blood phosphorus concentrations to reduce hypocalcemia risk in dairy cows.

Covalent linking of insulin A and B chains extends circulation half-life from minutes to hours, reducing injection frequency for diabetic patients.

INT131 activates PPARγ pathways to treat nonalcoholic fatty liver disease, resolving insulin resistance without edemagenic side effects.

UNA-modified siRNA oligomers cross the blood-brain barrier to reduce mutant gene expression in polyglutamine diseases.

Co-administering L-ascorbic acid with statins blocks alkaline phosphatase activity and calcium accumulation, preventing statin-induced vascular calcification.

Mannitol and propylene glycol stabilize GLP-1 in aqueous multi-dose formulations, preventing aggregation caused by phenol preservatives.

Staged oil addition and non-polar solvent extraction remove impurities from Blakeslea trispora mycelia, achieving 96% purity without toxic residues.

Targeted antibodies neutralize DENND1A.V2 to reduce hyperandrogenism by blocking CYP17A1 and CYP11A1 gene expression in PCOS theca cells.

Engineered multivalent lectins replace native proteins to eliminate mitogenicity while maintaining glucose responsiveness for safe controlled drug delivery.

Modulating PLXND1 and COL5A1 alters adipose tissue morphology, treating metabolic dysfunction linked to disrupted distribution.

Detecting NLRP1 mutations in PYD and LRR domains identifies predisposition to autoimmune skin disorders.

A multi-strain probiotic composition combined with policosanols targets obesity parameters through oral administration.

Segmented acellular scaffolds enable glucose-responsive insulin secretion by resolving ischemic injury from poor vascularization.

AcCSNLSTCVLGKLSQELHKLQTYPRTDVGANAP-NH2 peptide regulates glucose metabolism and reduces bone resorption.

Lactobacillus casei SGC-K probiotic reduces muscle wasting and improves insulin sensitivity in malnourished patients.

Placental alkaline phosphatase enhances protein synthesis in muscle cells to maintain tissue mass during critical illness.

Reducing starch branching enzyme II activity in wheat increases amylose content for improved metabolic health benefits.

Measuring glycated CD59 replaces short-term glucose snapshots with a stable indicator, improving diagnostic reliability without complex monitoring.

Engineered human alpha-galactosidase variants resolve enzyme instability and poor uptake in Fabry disease treatment via specific amino acid mutations.

Exendin-4 treats nonalcoholic steatohepatitis by reducing liver enzymes and minimizing hypoglycemic risks associated with traditional insulin therapy.

Optimized administration schemes for immunogenic peptides containing oxidoreductase motifs increase patient responsiveness by adjusting dosage parameters.

A synergistic blend of fructooligosaccharides, polyphenols, and multivitamins reduces fasting blood glucose and cholesterol levels.

Somaclonal variation and induced mutagenesis boost anthocyanin levels in red lettuce, addressing low antioxidant content found in conventional cultivars.

Covalent attachment of a di-fatty acid substituent to lysine positions extends the half-life of GLP-1/GIP/glucagon receptor triple agonists.

Hybrid compounds merge peptide binding domains with oligourea segments to resolve the contradiction between target affinity and cellular membrane permeability.

Anti-ActRIIB antibodies antagonize the ActRIIB pathway to decrease hepatic steatosis and address insufficient treatment options for fatty liver disease.

Pegylated arginase overcomes the slow reduction speed of dietary restrictions by rapidly lowering toxic metabolite levels.

Gemcabene reduces triglycerides by 52-61% without fibrates side effects.

Lactobacillus ONRICb0240 strain stimulates antibody production to resolve the lack of documented evidence for fatigue recovery agents.

Chitin shields water-soluble vitamins from thermal degradation during extrusion, maintaining nutrient stability in aquaculture feeds.

Fractionated tomato extract suppresses TNF-alpha and IL-6 to reduce side effects from conventional anti-inflammatory agents.

Cationic surfactants and RGD peptides enhance GLA entrapment efficiency while maintaining colloidal stability.

Lyophilizing concentrated guava leaf extract prevents precipitate formation during storage.

A food composition containing Schisandra chinensis fruit water and bean juice inhibits alpha-glucosidase activity to control blood glucose levels.

Recombinant adeno-associated virus delivers phenylalanine hydroxylase genes to liver cells, reducing plasma phenylalanine levels by up to 95%.

A bilayer tablet composition achieves excellent hardness through optimized compression parameters.

Inducing beige adipocytes via IL-4 and TGF-beta inhibitors overcomes weight loss sustainability issues by boosting thermogenesis.

Purified roasted coffee bean extract containing chlorogenic acids induces postprandial energy metabolism.